Results 1 to 10 of about 14,424,041 (271)

Discounted and Expected Utility from the Probability and Time Trade-Off Model [PDF]

open access: yesMathematics, 2020
This paper shows the interaction between probabilistic and delayed rewards. In decision- making processes, the Expected Utility (EU) model has been employed to assess risky choices whereas the Discounted Utility (DU) model has been applied to ...
Salvador Cruz Rambaud   +1 more
doaj   +5 more sources

Cost-utility analysis of home treatment versus inpatient treatment in child and adolescent psychiatry: a decision analysis [PDF]

open access: yesFrontiers in Child and Adolescent Psychiatry
IntroductionHealth-economic evidence comparing home treatment (HT) and inpatient treatment (IT) in child and adolescent psychiatry is scarce. This study assessed the cost-effectiveness of both interventions for children and adolescents in acute ...
Karolina Foremnik   +3 more
doaj   +2 more sources

Time preference, the discounted utility model and health [PDF]

open access: yesJournal of Health Economics, 1996
The constant rate discounted utility model is commonly used to represent intertemporal preferences in health care program evaluations. This paper examines the appropriateness of this model, and argues that the model fails both normatively and descriptively as a representation of individual intertemporal preferences for health outcomes.
Bleichrodt, Han, Gafni, A
openaire   +5 more sources

Economic evaluation of school scoliosis screening in Gannan Tibetan autonomous prefecture, Gansu Province: a cost-utility analysis based on decision tree-Markov model [PDF]

open access: yesFrontiers in Public Health
ObjectiveThis study evaluates the cost-utility of school-based scoliosis screening for adolescents in resource-limited settings to inform regional school health and disease control policies.MethodsWe performed a model-based cost-utility analysis using ...
Shaobo Yang   +14 more
doaj   +2 more sources

Economic evaluation of hearing aid use and quality of life in older adults with hearing impairment in India [PDF]

open access: yesFrontiers in Medical Technology
Hearing impairment is a growing public health challenge among older adults in India, with low uptake of hearing aids despite potential benefits for communication, social participation, and health-related quality of life (HRQoL).
Rakesh Kumar Sahoo   +8 more
doaj   +2 more sources

Discount models in intertemporal choice: an empirical analysis [PDF]

open access: yesEuropean Journal of Management and Business Economics, 2021
Purpose – The main purpose of this paper is to determine the discount function which better fits the individuals' preferences through the empirical analysis of the different functions used in the field of intertemporal choice. Design/methodology/approach
Isabel María Parra Oller   +2 more
doaj   +1 more source

Price Attractiveness and Price Complexity: Why People Prefer Level-Payment Loans

open access: yesFrontiers in Psychology, 2021
The improving sequence effect suggests that in choices between a rising earning and any other sequences, participants prefer the rising earning. Recent studies show that the improving sequence effect also exists in a loan context.
Yang Lu   +4 more
doaj   +1 more source

Cost-utility analysis of using paliperidone palmitate in schizophrenia in China

open access: yesFrontiers in Pharmacology, 2023
Objective: Long-acting injections (LAIs) of paliperidone palmitate have been shown to improve medication adherence and relieve psychotic symptoms. However, the specific cost-utility analysis of these LAIs in schizophrenia in China remains unclear.Methods:
Rui Luo, He Lu, Hengfen Li
doaj   +1 more source

Optimal Investment-Consumption Strategy of Household Based on CEV Model

open access: yesDiscrete Dynamics in Nature and Society, 2022
To maintain and increase household wealth, this study studies the optimal allocation ratio of household investment and consumption. When considering venture capital, it is assumed that the theoretical price of risky asset obeys the CEV model.
Aiyin Wang   +4 more
doaj   +1 more source

An updated cost-utility model for onasemnogene abeparvovec (Zolgensma®) in spinal muscular atrophy type 1 patients and comparison with evaluation by the Institute for Clinical and Effectiveness Review (ICER)

open access: yesJournal of Market Access & Health Policy, 2021
Background: Recent cost-utility analysis (CUA) models for onasemnogene abeparvovec (Zolgensma®, formerly AVXS-101) in spinal muscular atrophy type 1 (SMA1) differ on key assumptions and results.
Rebecca Dean   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy